Skip to site menu Skip to page content

Smith+Nephew introduces total ankle patient-matched guides

The guides will aid surgeons in planning and executing total ankle replacements to improve surgical outcomes.

Vishnu Priyan September 11 2024

Medical technology company Smith+Nephew has announced the launch of its ‘TOTAL ANKLE Patient-Matched Guides’.

These guides are designed to offer surgeons a predictable and efficient method for planning and executing total ankle replacement (TAR) procedures.

The all-in-one TOTAL ANKLE Patient-Matched Guides are created to have a precise patient fit utilising fluoroscopic alignment cues and instrumentation and offer accuracy to plan.

The guides are claimed to offer several advantages. Featuring integrated fluoroscopic cues, guide pins, and a cut slot to make the guide a comprehensive instrument, they provide predictability in the operating room.

The guides are also engineered for planning accuracy with their fluoroscopic alignment cues and instrumentation transfer pins.

The guides are also user-friendly offering tactile feedback with a medial arm wrap and ensuring a precise fit for the patient.

Smith+Nephew's partnership with 3D Systems was integral in designing and manufacturing the TOTAL ANKLE Patient-Matched Guides.

These guides are compatible with chamfer talar implants for Smith+Nephew’s CADENCE Total Ankle System and SALTO TALARIS Total Ankle Prosthesis, providing surgeons with the versatility to choose the best implant for their patients.

Smith+Nephew global trauma and extremities marketing vice-president Mark McMahan said: “We are excited to unveil our new TOTAL ANKLE Patient-Matched Guides for total ankle replacement - a breakthrough to help transform the way healthcare professionals approach surgical precision and improved patient outcomes.

“This advanced system is designed to offer unparalleled efficiency and accuracy, ultimately enhancing the overall experience for both surgeons and patients. The launch of our TOTAL ANKLE Patient-Matched Guides further strengthens our position as a leader in the total ankle replacement market segment.”

In July, the company received 510(k) clearance from the US Food and Drug Administration (FDA) for its CATALYSTEM Primary Hip System.

The system is designed to meet the evolving needs of primary hip surgery, including the expanding role of ambulatory surgery centres and the growing preference for anterior approach procedures.

The CATALYSTEM Primary Hip System has been developed using extensive global data sets across femoral morphologies, to ensure a precision fit.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close